EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • February 16th, 2021 • Rapid Therapeutic Science Laboratories, Inc. • Pharmaceutical preparations • Texas
Contract Type FiledFebruary 16th, 2021 Company Industry JurisdictionTHIS EXCLUSIVE LICENSE AGREEMENT (the “Agreement”) is made and entered into as of the 9th day of February 2021 (the “Effective Date”), by and between Rapid Therapeutic Science Laboratories, Inc., a Nevada corporation (the “Manufacturer”), EM3 Methodologies, LLC, an Arizona limited liability company, and Richard Adams, individually, a resident of Arizona (collectively the “Company”). Company and Manufacturer may be collectively referred to herein as the “Parties,” and individually as a “Party.”
EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • February 9th, 2021 • Rapid Therapeutic Science Laboratories, Inc. • Pharmaceutical preparations • Texas
Contract Type FiledFebruary 9th, 2021 Company Industry JurisdictionTHIS EXCLUSIVE LICENSE AGREEMENT (the “Agreement”) is made and entered into as of the 9th day of February 2021 (the “Effective Date”), by and between Rapid Therapeutic Science Laboratories, Inc., a Nevada corporation (the “Manufacturer”), EM3 Methodologies, LLC, an Arizona limited liability company, and Richard Adams, individually, a resident of Arizona (collectively the “Company”). Company and Manufacturer may be collectively referred to herein as the “Parties,” and individually as a “Party.”